Burosumab therapy in adult patients with X-linked hypophosphatemia: a three-year follow-up study

被引：0
|
作者：
Rotondi, Silverio [1 ]
Tartaglione, Lida [1 ]
Pasquali, Marzia [1 ]
Cacchioni, Carlotta [1 ]
Tinti, Francesca [1 ]
Perrotta, Adolfo Marco [1 ]
Punzo, Alessandra [1 ]
Lai, Silvia [1 ]
Mazzaferro, Sandro [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2015
引用
收藏
页码：I409 / I410
页数：2
相关论文
共 50 条
  • [1] THERAPYWITH BUROSUMAB IN ADULT PATIENTSWITH X-LINKED HYPOPHOSPHATEMIA: A YEAR OF FOLLOW-UP
    Rotondi, Silverio
    Tartaglione, Lida
    Perrotta, Adolfo
    Carroccia, Nadia
    Pasquali, Marzia
    Mazzaferro, Sandro
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I222 - I223
  • [2] Burosumab Therapy in Children with X-Linked Hypophosphatemia
    Carpenter, Thomas O.
    Whyte, Michael P.
    Imel, Erik A.
    Boot, Annemieke M.
    Hogler, Wolfgang
    Linglart, Agnes
    Padidela, Raja
    van't Hoff, William
    Mao, Meng
    Chen, Chao-Yin
    Skrinar, Alison
    Kakkis, Emil
    San Martin, Javier
    Portale, Anthony A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (21): : 1987 - 1998
  • [3] Population Pharmacokinetics and Pharmacodynamics of Burosumab in Adult and Pediatric Patients With X-linked Hypophosphatemia
    Lee, Sun Ku
    Gosselin, Nathalie H.
    Taylor, Julie
    Roberts, Mary Scott
    McKeever, Kathleen
    Shi, Jack
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (01): : 87 - 98
  • [4] Burosumab Therapy for X-Linked Hypophosphatemia and Therapeutic Implications for CKD
    Perwad, Farzana
    Portale, Anthony A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1097 - 1099
  • [5] Three-Year Safety and Efficacy Results of Burosumab for Children Aged 1 to 4 years with X-linked Hypophosphatemia (XLH)
    Imel, Erik
    Carpenter, Thomas
    Gottesman, Gary
    Chen, Angel
    Skrinar, Alison
    Roberts, Mary Scott
    Whyte, Michael P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 16 - 16
  • [6] Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy
    Brener, Rafi
    Zeitlin, Leonid
    Lebenthal, Yael
    Brener, Avivit
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Longitudinal Follow Up of Mother-Daughter Pair With X-Linked Hypophosphatemia: Benefits of Burosumab Versus Conventional Therapy
    Alvarez, Ana Gutierrez
    Litao, Melissa Kaori Silva
    Shah, Bina
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 36 - 36
  • [8] Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia
    Zhukouskaya, Volha V.
    Ertl, Diana-Alexandra
    Berkenou, Jugurtha
    Audrain, Christelle
    Bardet, Claire
    Rothenbuhler, Anya
    Linglart, Agnes
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 33 - 33
  • [9] Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
    Martin Ramos, Silvia
    Gil-Calvo, Marta
    Roldan, Virginia
    Castellano Martinez, Ana
    Santos, Fernando
    [J]. FRONTIERS IN PEDIATRICS, 2020, 8
  • [10] Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
    Brener, Avivit
    Cleper, Roxana
    Baruch, Guy
    Rothschild, Ehud
    Yackobovitch-Gavan, Michal
    Beer, Gil
    Zeitlin, Leonid
    Kapusta, Livia
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345